Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Rybelsus (semaglutide) Tablets 3 mg provide an accessible and effective entry point for type 2 diabetes management, empowering patients with an impactful oral therapy option that fits seamlessly into daily routines under guidance from healthcare providers
Head of Medical Affairs BSc (Hons), MSc, PhD Dr
Pricing may vary based on your individualized dosage and program phase
Figure 2c: From step 1 (left) to steps 2 and 3 (right)
PMID: 9403790
The PIONEER 3 study (Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial), consisting of 1864 subjects, tested the effectiveness of Rybelsus to Januvia (another DPP-4 inhibitor)
